Yahoo Finance • 2 months ago
Product sales from Olverembatinib in the first half of 2025 increased 93%year-over-year to US$30.3 million (RMB217.4 million), primarily attributable to the expansion of NRDL coverageCommenced commercial sales of Lisaftoclax in China, foll... Full story
Yahoo Finance • 2 months ago
ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization... Full story
Yahoo Finance • 2 months ago
ROCKVILLE, Md. and SUZHOU, China, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet m... Full story
Yahoo Finance • 3 months ago
Ascentage Pharma Group International (NASDAQ:AAPG) is one of the best young stocks to buy and hold for 5 years. On July 10, Ascentage Pharma announced that China’s National Medical Products Administration/NMPA approved its novel Bcl-2 sele... Full story
Yahoo Finance • 3 months ago
ROCKVILLE, Md. and SUZHOU, China - Ascentage Pharma Group International Inc. (NASDAQ:AAPG; HKEX:6855), which has seen its stock surge 120% over the past year according to InvestingPro data, announced Monday the pricing of 22 million ordina... Full story
Yahoo Finance • 3 months ago
By Karen Roman Ascentage Pharma Group International (Nasdaq: AAPG) said it designated Veet Misra, Ph.D., as Chief Financial Officer, and Eric Huang as Senior Vice President of Global Corporate Development and Finance. Dr. Misra has more... Full story
Yahoo Finance • 5 months ago
We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look at where Ascentage Pharma Group Internat (NASDAQ:AAPG) stands against other best performing healthcare stocks to... Full story